Myopia

A new classification system helps patients reach informed decisions.

In an AAOpt poster, Dr. Mark Bullimore investigates the definition of "normal progression" in myopic eyes and the change of efficacy over time.

Increased choroidal thickness also was seen in children treated with 1% atropine for 1 week or 0.01% atropine for less than 8 weeks.

Six topics were assessed in the report, including global data on myopia prevalence, technology, environmental and genetic contributions to myopia onset and progression, and mechanistic causes of myopia pathogenesis, among others.

Understanding and balancing digital exposure in children can reduce myopia progression.

By alternating the focus area—or the clear zone of the lens—and defocus area—the honeycomb-shaped segment of the lens—the spectacle lenses achieve clear vision and manage myopia progression.

Pediatric optometrist Dr. Magdalena Stec highlights effective treatment options and practical advice for parents to help manage and control myopia in their kids.

Adam S. Wenick, MD, PhD, discussed myopia interventions across the lifespan at EyeCon 2024, covering treatments, complications, and prevention strategies.

Brianna Rhue, OD, FAAO, FSLS, shares her passion for myopia management and control at this year's Vision Expo West.

An inside look into a retrospective study conducted from 2019 to 2023 that aimed to assess the effectiveness of treatment and prevention of the progression of uncomplicated acquired myopia through physiotherapeutic methods.

Resources available during the month include a seminar series and course bundles.

Living a long life and preserving eye health can go hand in hand.

The strike force involves more than a dozen medical and nonmedical professionals to help bridge the gap between failed vision screenings and follow-up examinations.

Exploring myopia control treatment efficacy does not demand clinical complexity.

How myopia management reinvigorated me and my practice.

A recent study found that adolescents with myopia that were 16 to 20 years old were twice as likely to develop anxiety and mood disorders.

Educating parents of pediatric patients starts with getting staff on the same page.

Mandy Sallach, OD, overviews initiatives being taken on by the company to combat pediatric myopia.

Drs Clark Chang and Tracy Lynn Schroeder Swartz give an overview of their Optometry's Meeting talk on detecting keratoconus early, providing tips for the proper technology to use and how to properly detect high-risk patients.

Over 60 eye care professionals from all 50 states were selected to help shift the focus of pediatric myopia care from correction to comprehensive treatment.

The company’s initiatives include involvement with the Global Myopia Awareness Coalition and discounting blue light screen protectors and its pediatric eye care program, among others.

Investigators found more cases than expected following tomography of 2007 eyes.

MyopiaX is a non-invasive, light-based treatment that uses a virtual reality headset to deliver treatment while patients engage with digital content.

Representatives from CooperVision and the International Agency for the Prevention of Blindness give a preview of what to expect at the "Universal Access to Glasses: Promoting Multisectoral Action" event at this year's World Health Assembly in Geneva, Switzerland.

Noel Brennan, MScOptom, PhD, overviews his ARVO 2024 presentation on reimagining the prediction of longer term efficacy numbers in data from pediatric trials evaluating myopia.

Ricardo Pintor, OD, FIACLE, gives an overview of the World Council of Optometry’s first Latin America–based virtual event and what challenges Latin America faces in terms of myopia.

CIME Cochair Neda Shamie, MD, gives an overview of presentations on Demodex blepharitis, LASIK, retina sessions, and more at this year's conference.

This study also found that upon discontinuation, myopia development did not rebound, with NVK002 0.01% as a potential long-term treatment for pediatric myopia.

David A. Berntsen, OD, PhD, FAAO, talks through his 2024 ARVO presentation on the BLINK2 study and the findings on axial growth after discontinuing soft multifocal contact lens wear.